Adrian N. Hobden
Directeur Général chez Cerespir, Inc.
Profil
Dr. Adrian N.
Hobden is a Scientific Advisor at Frantz Medical Ventures and he is the President, Chief Executive Officer & Director at Myrexis, Inc. He is on the Board of Directors at Myrexis, Inc.
Dr. Hobden was previously employed as President by Myriad Genetics, Inc. He also served on the board at Glaxo Wellcome, Inc.
Dr. Hobden received his undergraduate degree from the University of Cambridge, a graduate degree from the University of Cambridge, and a doctorate degree from the University of Leicester.
Postes actifs de Adrian N. Hobden
| Sociétés | Poste | Début |
|---|---|---|
Frantz Medical Ventures
 Frantz Medical Ventures Investment ManagersFinance Frantz Medical Ventures (Frantz Medical Ventures) is a venture capital subsidiary of Frantz Medical Group founded in 1979. The firm is headquartered in Mentor, Ohio. | Private Equity Investor | - |
Cerespir, Inc.
 Cerespir, Inc. Pharmaceuticals: MajorHealth Technology Cerespir, Inc. operates as pharmaceutical company. It develops molecules for the treatment of Alzheimer disease. The company was founded by Daniel G. Chain in November 2013 and is headquartered in New York, NY. | Directeur Général | - |
Cambridge in America
 Cambridge in America Miscellaneous Commercial ServicesCommercial Services Cambridge in America provides alumni network relations services. They help build a community of Cambridge University alumni and friends throughout the United States. The company was founded in 2000 and is headquartered in New York, NY. | Directeur/Membre du Conseil | - |
Anciens postes connus de Adrian N. Hobden
| Sociétés | Poste | Fin |
|---|---|---|
| MYREXIS, INC. | Directeur Général | 21/07/2011 |
| Glaxo Wellcome, Inc. | Corporate Officer/Principal | 01/10/1998 |
| MYRIAD GENETICS, INC. | President | - |
Formation de Adrian N. Hobden
| University of Leicester | Doctorate Degree |
| University of Cambridge | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| MYREXIS, INC. | Finance |
| MYRIAD GENETICS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Frantz Medical Ventures
Frantz Medical Ventures Investment ManagersFinance Frantz Medical Ventures (Frantz Medical Ventures) is a venture capital subsidiary of Frantz Medical Group founded in 1979. The firm is headquartered in Mentor, Ohio. | Finance |
| Glaxo Wellcome, Inc. | Health Technology |
Cerespir, Inc.
Cerespir, Inc. Pharmaceuticals: MajorHealth Technology Cerespir, Inc. operates as pharmaceutical company. It develops molecules for the treatment of Alzheimer disease. The company was founded by Daniel G. Chain in November 2013 and is headquartered in New York, NY. | Health Technology |
Cambridge in America
Cambridge in America Miscellaneous Commercial ServicesCommercial Services Cambridge in America provides alumni network relations services. They help build a community of Cambridge University alumni and friends throughout the United States. The company was founded in 2000 and is headquartered in New York, NY. | Commercial Services |
